Mineralys Therapeutics Inc.
Clinical trials sponsored by Mineralys Therapeutics Inc., explained in plain language.
-
New pill could ease sleep apnea and lower blood pressure
Disease control CompletedThis study tested a daily pill called lorundrostat in 48 adults with moderate-to-severe obstructive sleep apnea and high blood pressure. The goal was to see if the drug could reduce breathing pauses during sleep and lower nighttime blood pressure. Participants took the drug or a …
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New pill could tame stubborn high blood pressure
Disease control CompletedThis study tested a new drug called lorundrostat in 1083 adults whose high blood pressure remained high despite taking 2 to 5 other blood pressure medicines. The goal was to see if adding lorundrostat could lower blood pressure more than a placebo. Participants took the drug or a…
Phase: PHASE3 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated May 12, 2026 13:43 UTC
-
New pill could help millions with stubborn high blood pressure
Disease control CompletedThis study tested a new drug called lorundrostat in 285 adults whose high blood pressure remained uncontrolled despite taking 2 to 5 other medications. Participants added either lorundrostat or a placebo to their current regimen. The goal was to see if lorundrostat could safely l…
Phase: PHASE2 • Sponsor: Mineralys Therapeutics Inc. • Aim: Disease control
Last updated May 06, 2026 16:13 UTC